Dosage form for treating central nervous system disorders
US5192550A · kind A · utility
83Cited by
15References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 5, 1992 |
| Grant date | Mar 9, 1993 |
| Priority date | — |
| Expiry date | Mar 5, 2012 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/0004
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A dosage form is disclosed comprising an anti-Parkinson's disease drug for administering to a patient in need of anti-Parkinson's disease therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.